insights

Using Functional Medicine to Reverse Type II Diabetes

How can we help patients with the health outcomes that matter to them most? Many patients with cardiometabolic syndrome or diabetes want to know what they can do to preserve their vision, preserve renal function, and reduce foot problems and dental disease. The current standard of care often highlights glycemic control, but recent research indicates that this metric may not be delivering the health outcomes patients want. Going beyond a singular focus on glycemic control may be necessary to help patients attain the health outcomes they desire.

A Functional Medicine approach can help control glycemic indices, and it may also help reduce many related health issues. In particular, using dietary change as a first-line treatment has shown success in reversing diabetes. In Kristine Burke, MD’s, practice, not only did 75% of program participants enjoy normalization of their A1c and blood sugar numbers, many were also able to stop their diabetes medication(s). Watch her describe the diabetes reversal program:

Kristine Burke, MD, is board certified in family medicine and sports medicine and certified in Functional Medicine. She is the medical director for Help Your Diabetes – Sacramento and has practiced family medicine since 1997.

Learn more about Functional Medicine

A 2016 analysis found that diabetic retinopathy and associated vision impairment have been increasing steadily around the world, despite a focus on glycemic control.1 Renal failure and neuropathy also showed no improvements.1 This is despite the increased focus on glycemic control, now supported by a variety of clinical guidelines.2 The prevalence of diabetes is estimated to increase to 629 million by 2045.3

The focus on glycemic control is costly and is generally not supported by the literature. A joint Canadian-US study estimated the annual cost of hypoglycemia resulting from tight glycemic control in older adults was $65,497,849 in Canada and $509,214,473 in the US.2 In a review, Mayo Clinic researchers found that tight glycemic control was not supported by research; it did not lower the risk of progression to dialysis, renal transplant, blindness, neuropathy, all-cause mortality, or stroke.2 Further, tight glycemic control in the frail elderly can actually lead to hypoglycemia and dementia4 and can create as well as treat episodes of neuropathy.5 While medications can normalize glucose numbers, this approach fails to stem the tide of diabetes complications. Research suggests that diet-based approaches have greater success, including ?-3 fatty acid interventions that research suggests can successfully reduce retinopathy.6

At least for some patients, exercise and nutrition interventions may outperform medications. For example, in one Danish study, reduction in glucose-lowering medications was achieved by 47 participants (73.5%) in the lifestyle group compared to only nine participants with improvements (26.4%) in the standard care group.7 The intervention consisted of an aerobic training program along with a dietary plan for achieving a BMI of less than 25.7 In another study, participants with poor glycemic control who undertook a multidisciplinary lifestyle regimen enjoyed significant improvements in A1c, BMI, waist circumference, and blood pressure up to two years after the study.8

IFM provides clinicians with tools to help their patients adopt heathy lifestyle practices, such as eating more high-quality foods that are rich in phytonutrients and increasing physical activity. For more information, follow the links below.

Learn More About Cardiometabolic Function

The right food plan for cardiometabolic patients

The Diet, Nutrition, and Lifestyle Journal helps patients track daily choices

References

  1. Leasher JL, Bourne RR, Flaxman SR, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care. 2016;39(9):1643-1649. doi:2337/dc15-2171
  2. Rodríguez-Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes. 2016;9(5):504-512. doi:1161/CIRCOUTCOMES.116.002901
  3. Forouhi NG, Misra A, Mohan V, Taylor R, Yancy W. Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ. 2018;361:k2234. doi:1136/bmj.k2234
  4. Boulin M, Diaby V, Tannenbaum C. Preventing unnecessary costs of drug-induced hypoglycemia in older adults with type 2 diabetes in the United States and Canada. PLoS One. 2016;11(9):e0162951. doi:1371/journal.pone.0162951
  5. Abdelhafiz AH, McNicholas E, Sinclair AJ. Hypoglycemia, frailty and dementia in older people with diabetes: reciprocal relations and clinical implications. J Diabetes Complications. 2016;30(8):1548-1554. doi:1016/j.jdiacomp.2016.07.027
  6. Sala-Vila A, Díaz-López A, Valls-Pedret C, et al. Dietary marine ?-3 fatty acids and incident sight-threatening retinopathy in middle-aged and older individuals with type 2 diabetes: prospective investigation from the PREDIMED trial. JAMA Ophthalmol. 2016;134(10):1142-1149. doi:1001/jamaophthalmol.2016.2906
  7. Johansen MY, MacDonald CS, Hansen KB, et al. Effect of an intensive lifestyle intervention on glycemic control in patients with type 2 diabetes: a randomized clinical trial. 2017;318(7):637-646. doi:10.1001/jama.2017.10169
  8. Sbroma Tomaro E, Pippi R, Reginato E, et al. Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes. Nutr Metab Cardiovasc Dis. 2017;27(8):688-694. doi:1016/j.numecd.2017.06.009

Related Insights

Insights
Group 2

Building ATP Levels for Patients With Heart Failure

The heart’s ability to store energy is limited. A continuous process to fuel the mitochondria by stimulating ATP production is a focus of new heart failure treatment strategies.

Read More
Insights
Group 2

The Connection Between POPs and Metabolic Syndrome

What could be causing the global rise in metabolic syndrome and diabetes? One line of research points to persistent organic pollutants (POPs). How can clinicians manage exposures to these ubiquitous chemicals?

Read More
Insights
Group 2

Lifestyle Interventions for Patients With Metabolic Syndrome

Metabolic syndrome, characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia, is now considered a major health hazard and has even been called a “global pandemic.” Researchers suggest that an increase in high-calorie, low-fiber fast food, more sedentary lifestyles, and a decrease in physical activity contribute to the rising incidence of metabolic syndrome.

Read More